True Ileal Amino Acid Digestibility of Tenebrio Molitor Larvae in Women
NCT ID: NCT05885191
Last Updated: 2024-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2023-08-30
2024-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uptake and Utilization of Amino Acids by Splanchnic Bed
NCT01032616
Chromium Contamination of Parenteral Nutrition
NCT03906890
Metronidazole Pharmacokinetics (PK) in Premature Infants
NCT01222585
Teduglutide in Short Bowel Syndrome Patients
NCT04857801
Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome
NCT03105362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2H intrinsically-labeled T.molitor
1 portion of bread and vegetable soup prepared with dried 2H intrinsically labeled T.molitor and 13C labeled reference amino acid mixture
2H intrinsically-labeled T.molitor with 13-C labeled amino acid mixture
Test meal with dried 2H intrinsically labeled T.molitor and 13C labeled reference amino acid mixture will be divided into 10 portions, which will be given hourly over the course of 7 hours. The first consumption will be the priming meal, comprised of 3 portions and will additionally contain 13C sodium bicarbonate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2H intrinsically-labeled T.molitor with 13-C labeled amino acid mixture
Test meal with dried 2H intrinsically labeled T.molitor and 13C labeled reference amino acid mixture will be divided into 10 portions, which will be given hourly over the course of 7 hours. The first consumption will be the priming meal, comprised of 3 portions and will additionally contain 13C sodium bicarbonate.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal BMI (18.5 - 25 kg/m2)
* Body weight \< 60 kg
* Signed informed consent
* Able to communicate and comprehend English
* Are open-minded towards consuming insect-based meals
Exclusion Criteria
* Inflammation (CRP \> 5.0 mg/L)
* Pregnancy or intention to become pregnant during the study or within 30 days after the discontinuation of the study intervention
* Lactating up to 6 weeks before the study initiation
* Chronic digestive, renal and/or metabolic diseases
* Antibiotics in the last 4 weeks prior to the study and during the study
* Mineral and vitamin supplementation in the last 2 weeks prior to the study
* Chronic medication intake (except for oral contraceptives)
* Daily exercise routine of high intensity
* Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months
* Participation in any clinical study within the last 30 days
* Food allergies, especially hypersensitivity to crustacea, dust mites, sea food, gluten, milk, or eggs
* History of serious illness or infection within 3 months of the study
* Cigarette smoking (\> 1 cigarette per day)
* Difficulties with blood or breath sampling
* Participants who cannot be expected to comply with study protocol (e.g., not available for the full 8.5 hours of the study day or unable to follow fasting period)
* Inability to understand the information sheet and the informed consent form due to cognitive or language reasons
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Distance University of Applied Sciences
OTHER
Swiss Federal Institute of Technology
OTHER
St. John's Research Institute
OTHER
Wageningen University and Research
OTHER
Diego Moretti
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diego Moretti
Head of Nutrition Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diego Moretti, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Swiss Distance University of Applied Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ETH Zurich, Laboratory of Human Nutrition
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TmD01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.